Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Jun;111(8):1055–1064. doi: 10.1289/ehp.6065

The role of genetic polymorphisms in environmental health.

Samir N Kelada 1, David L Eaton 1, Sophia S Wang 1, Nathaniel R Rothman 1, Muin J Khoury 1
PMCID: PMC1241554  PMID: 12826477

Abstract

Interest is increasing in the role of variations in the human genome (polymorphisms) in modifying the effect of exposures to environmental health hazards (often referred to as gene-environment interaction), which render some individuals or groups in the population more or less likely to develop disease after exposure. This review is intended for an audience of environmental health practitioners and students and is designed to raise awareness about this rapidly growing field of research by presenting established and novel examples of gene-environment interaction that illustrate the major theme of effect modification. Current data gaps are identified and discussed to illustrate limitations of past research and the need for the application of more robust methods in future research projects. Two primary benefits of incorporating genetics into the existing environmental health research framework are illustrated: a) the ability to detect different levels of risk within the population, and b) greater understanding of etiologic mechanisms. Both offer opportunities for developing new methods of disease prevention. Finally, we describe a basic framework for researchers interested in pursuing health effects research that incorporates genetic polymorphisms.

Full Text

The Full Text of this article is available as a PDF (170.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham L. J., Kroeger K. M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol. 1999 Oct;66(4):562–566. doi: 10.1002/jlb.66.4.562. [DOI] [PubMed] [Google Scholar]
  2. Adamiak W., Jadczyk P., Kucharczyk J. Application of Salmonella strains with altered nitroreductase and O-acetyltransferase activities to the evaluation of the mutagenicity of airborne particles. Acta Microbiol Pol. 1999;48(2):131–140. [PubMed] [Google Scholar]
  3. Ali-Osman F., Akande O., Antoun G., Mao J. X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997 Apr 11;272(15):10004–10012. doi: 10.1074/jbc.272.15.10004. [DOI] [PubMed] [Google Scholar]
  4. Arbour N. C., Lorenz E., Schutte B. C., Zabner J., Kline J. N., Jones M., Frees K., Watt J. L., Schwartz D. A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000 Jun;25(2):187–191. doi: 10.1038/76048. [DOI] [PubMed] [Google Scholar]
  5. Au W. W., Sierra-Torres C. H., Cajas-Salazar N., Shipp B. K., Legator M. S. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect. 1999 Jun;107(6):501–505. doi: 10.1289/ehp.99107501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res. 2000 Jan 3;464(1):65–76. doi: 10.1016/s1383-5718(99)00167-9. [DOI] [PubMed] [Google Scholar]
  7. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):3–28. [PubMed] [Google Scholar]
  8. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998 Dec 1;58(23):5291–5293. [PubMed] [Google Scholar]
  9. Bennett W. P., Alavanja M. C., Blomeke B., Vähäkangas K. H., Castrén K., Welsh J. A., Bowman E. D., Khan M. A., Flieder D. B., Harris C. C. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst. 1999 Dec 1;91(23):2009–2014. doi: 10.1093/jnci/91.23.2009. [DOI] [PubMed] [Google Scholar]
  10. Beskow L. M., Burke W., Merz J. F., Barr P. A., Terry S., Penchaszadeh V. B., Gostin L. O., Gwinn M., Khoury M. J. Informed consent for population-based research involving genetics. JAMA. 2001 Nov 14;286(18):2315–2321. doi: 10.1001/jama.286.18.2315. [DOI] [PubMed] [Google Scholar]
  11. Botto L. D., Khoury M. J. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001 May 15;153(10):1016–1020. doi: 10.1093/aje/153.10.1016. [DOI] [PubMed] [Google Scholar]
  12. Bouchardy C., Mitrunen K., Wikman H., Husgafvel-Pursiainen K., Dayer P., Benhamou S., Hirvonen A. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics. 1998 Aug;8(4):291–298. doi: 10.1097/00008571-199808000-00002. [DOI] [PubMed] [Google Scholar]
  13. Brockton N., Little J., Sharp L., Cotton S. C. N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000 May 1;151(9):846–861. doi: 10.1093/oxfordjournals.aje.a010289. [DOI] [PubMed] [Google Scholar]
  14. Brookes A. J. The essence of SNPs. Gene. 1999 Jul 8;234(2):177–186. doi: 10.1016/s0378-1119(99)00219-x. [DOI] [PubMed] [Google Scholar]
  15. Brüning T., Lammert M., Kempkes M., Thier R., Golka K., Bolt H. M. Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol. 1997;71(9):596–599. doi: 10.1007/s002040050432. [DOI] [PubMed] [Google Scholar]
  16. Caporaso N., Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics. 1995 Apr;5(2):59–63. doi: 10.1097/00008571-199504000-00001. [DOI] [PubMed] [Google Scholar]
  17. Caporaso N., Rothman N., Wacholder S. Case-control studies of common alleles and environmental factors. J Natl Cancer Inst Monogr. 1999;(26):25–30. doi: 10.1093/oxfordjournals.jncimonographs.a024222. [DOI] [PubMed] [Google Scholar]
  18. Caporaso N. Selection of candidate genes for population studies. IARC Sci Publ. 1999;(148):23–36. [PubMed] [Google Scholar]
  19. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C. R., Lim E. P., Kalyanaraman N. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231–238. doi: 10.1038/10290. [DOI] [PubMed] [Google Scholar]
  20. Carr B. A., Franklin M. R. Drug-metabolizing enzyme induction by 2,2'-dipyridyl, 1,7-phenanthroline, 7,8-benzoquinoline and oltipraz in mouse. Xenobiotica. 1998 Oct;28(10):949–956. doi: 10.1080/004982598239010. [DOI] [PubMed] [Google Scholar]
  21. Cartwright R. A., Glashan R. W., Rogers H. J., Ahmad R. A., Barham-Hall D., Higgins E., Kahn M. A. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet. 1982 Oct 16;2(8303):842–845. doi: 10.1016/s0140-6736(82)90810-8. [DOI] [PubMed] [Google Scholar]
  22. Cascorbi I., Roots I., Brockmöller J. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res. 2001 Jul 1;61(13):5051–5056. [PubMed] [Google Scholar]
  23. Chao Y. C., Wang L. S., Hsieh T. Y., Chu C. W., Chang F. Y., Chu H. C. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis. Am J Gastroenterol. 2000 Oct;95(10):2958–2964. doi: 10.1111/j.1572-0241.2000.02328.x. [DOI] [PubMed] [Google Scholar]
  24. Chida M., Yokoi T., Fukui T., Kinoshita M., Yokota J., Kamataki T. Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res. 1999 Sep;90(9):899–902. doi: 10.1111/j.1349-7006.1999.tb00832.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chiou H. Y., Hsueh Y. M., Hsieh L. L., Hsu L. I., Hsu Y. H., Hsieh F. I., Wei M. L., Chen H. C., Yang H. T., Leu L. C. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res. 1997 Jun;386(3):197–207. doi: 10.1016/s1383-5742(97)00005-7. [DOI] [PubMed] [Google Scholar]
  26. Colvin M. E., Hatch F. T., Felton J. S. Chemical and biological factors affecting mutagen potency. Mutat Res. 1998 May 25;400(1-2):479–492. doi: 10.1016/s0027-5107(98)00073-6. [DOI] [PubMed] [Google Scholar]
  27. Cooper G. S., Umbach D. M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res. 1996 Dec;11(12):1841–1849. doi: 10.1002/jbmr.5650111203. [DOI] [PubMed] [Google Scholar]
  28. Deitz A. C., Zheng W., Leff M. A., Gross M., Wen W. Q., Doll M. A., Xiao G. H., Folsom A. R., Hein D. W. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905–910. [PubMed] [Google Scholar]
  29. Duell E. J., Wiencke J. K., Cheng T. J., Varkonyi A., Zuo Z. F., Ashok T. D., Mark E. J., Wain J. C., Christiani D. C., Kelsey K. T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000 May;21(5):965–971. doi: 10.1093/carcin/21.5.965. [DOI] [PubMed] [Google Scholar]
  30. Dybdahl M., Vogel U., Frentz G., Wallin H., Nexø B. A. Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):77–81. [PubMed] [Google Scholar]
  31. Eaton D. L. Biotransformation enzyme polymorphism and pesticide susceptibility. Neurotoxicology. 2000 Feb-Apr;21(1-2):101–111. [PubMed] [Google Scholar]
  32. Eaton D. L., Gallagher E. P., Bammler T. K., Kunze K. L. Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics. 1995 Oct;5(5):259–274. doi: 10.1097/00008571-199510000-00001. [DOI] [PubMed] [Google Scholar]
  33. Engel Lawrence S., Taioli Emanuela, Pfeiffer Ruth, Garcia-Closas Montserrat, Marcus Pamela M., Lan Qing, Boffetta Paolo, Vineis Paolo, Autrup Herman, Bell Douglas A. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol. 2002 Jul 15;156(2):95–109. doi: 10.1093/aje/kwf018. [DOI] [PubMed] [Google Scholar]
  34. Evans W. E., Relling M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999 Oct 15;286(5439):487–491. doi: 10.1126/science.286.5439.487. [DOI] [PubMed] [Google Scholar]
  35. Fan F., Liu C., Tavaré S., Arnheim N. Polymorphisms in the human DNA repair gene XPF. Mutat Res. 1999 Aug;406(2-4):115–120. doi: 10.1016/s1383-5726(99)00008-4. [DOI] [PubMed] [Google Scholar]
  36. Fleming D. E., Chettle D. R., Wetmur J. G., Desnick R. J., Robin J. P., Boulay D., Richard N. S., Gordon C. L., Webber C. E. Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res. 1998 Apr;77(1):49–61. doi: 10.1006/enrs.1997.3818. [DOI] [PubMed] [Google Scholar]
  37. Furlong Clement E., Cole Toby B., Jarvik Gail P., Costa Lucio G. Pharmacogenomic considerations of the paraoxonase polymorphisms. Pharmacogenomics. 2002 May;3(3):341–348. doi: 10.1517/14622416.3.3.341. [DOI] [PubMed] [Google Scholar]
  38. Gallagher E. P., Kunze K. L., Stapleton P. L., Eaton D. L. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol. 1996 Dec;141(2):595–606. doi: 10.1006/taap.1996.0326. [DOI] [PubMed] [Google Scholar]
  39. Garcia-Closas M., Rothman N., Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1043–1050. [PubMed] [Google Scholar]
  40. García-Closas M., Egan K. M., Abruzzo J., Newcomb P. A., Titus-Ernstoff L., Franklin T., Bender P. K., Beck J. C., Le Marchand L., Lum A. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):687–696. [PubMed] [Google Scholar]
  41. Gil J. P., Lechner M. C. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis. 1998 Jan;19(1):37–41. doi: 10.1093/carcin/19.1.37. [DOI] [PubMed] [Google Scholar]
  42. Grandchamp B., Lamoril J., Puy H. Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria. J Bioenerg Biomembr. 1995 Apr;27(2):215–219. doi: 10.1007/BF02110036. [DOI] [PubMed] [Google Scholar]
  43. Hadi M. Z., Coleman M. A., Fidelis K., Mohrenweiser H. W., Wilson D. M., 3rd Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res. 2000 Oct 15;28(20):3871–3879. doi: 10.1093/nar/28.20.3871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Hanke J., Krajewska B. Acetylation phenotypes and bladder cancer. J Occup Med. 1990 Sep;32(9):917–918. doi: 10.1097/00043764-199009000-00032. [DOI] [PubMed] [Google Scholar]
  45. Hassett C., Aicher L., Sidhu J. S., Omiecinski C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994 Mar;3(3):421–428. doi: 10.1093/hmg/3.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991 Oct;110(4):559–565. doi: 10.1093/oxfordjournals.jbchem.a123619. [DOI] [PubMed] [Google Scholar]
  47. Heath E. M., Morken N. W., Campbell K. A., Tkach D., Boyd E. A., Strom D. A. Use of buccal cells collected in mouthwash as a source of DNA for clinical testing. Arch Pathol Lab Med. 2001 Jan;125(1):127–133. doi: 10.5858/2001-125-0127-UOBCCI. [DOI] [PubMed] [Google Scholar]
  48. Hein D. W., Doll M. A., Fretland A. J., Leff M. A., Webb S. J., Xiao G. H., Devanaboyina U. S., Nangju N. A., Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29–42. [PubMed] [Google Scholar]
  49. Hein D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J., Grant D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis. 1993 Aug;14(8):1633–1638. doi: 10.1093/carcin/14.8.1633. [DOI] [PubMed] [Google Scholar]
  50. Hori H., Kawano T., Endo M., Yuasa Y. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. J Clin Gastroenterol. 1997 Dec;25(4):568–575. doi: 10.1097/00004836-199712000-00003. [DOI] [PubMed] [Google Scholar]
  51. Houlston R. S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):675–682. [PubMed] [Google Scholar]
  52. Hu J. J., Smith T. R., Miller M. S., Mohrenweiser H. W., Golden A., Case L. D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001 Jun;22(6):917–922. doi: 10.1093/carcin/22.6.917. [DOI] [PubMed] [Google Scholar]
  53. Humbert R., Adler D. A., Disteche C. M., Hassett C., Omiecinski C. J., Furlong C. E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 1993 Jan;3(1):73–76. doi: 10.1038/ng0193-73. [DOI] [PubMed] [Google Scholar]
  54. Ingelman-Sundberg M., Oscarson M., McLellan R. A. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci. 1999 Aug;20(8):342–349. doi: 10.1016/s0165-6147(99)01363-2. [DOI] [PubMed] [Google Scholar]
  55. Kelada S. N., Shelton E., Kaufmann R. B., Khoury M. J. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol. 2001 Jul 1;154(1):1–13. doi: 10.1093/aje/154.1.1. [DOI] [PubMed] [Google Scholar]
  56. Kelsey K. T., Wiencke J. K., Ward J., Bechtold W., Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat Res. 1995 Dec;335(3):267–273. doi: 10.1016/0165-1161(95)00030-5. [DOI] [PubMed] [Google Scholar]
  57. Kensler T. W., Curphey T. J., Maxiutenko Y., Roebuck B. D. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol Drug Interact. 2000;17(1-4):3–22. doi: 10.1515/dmdi.2000.17.1-4.3. [DOI] [PubMed] [Google Scholar]
  58. Kleeberger S. R., Reddy S., Zhang L. Y., Jedlicka A. E. Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol. 2000 May;22(5):620–627. doi: 10.1165/ajrcmb.22.5.3912. [DOI] [PubMed] [Google Scholar]
  59. Knudsen L. E., Norppa H., Gamborg M. O., Nielsen P. S., Okkels H., Soll-Johanning H., Raffn E., Järventaus H., Autrup H. Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):303–310. [PubMed] [Google Scholar]
  60. Koyama H., Geddes D. M. Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease. Thorax. 1998 Aug;53 (Suppl 2):S10–S14. doi: 10.1136/thx.53.2008.s10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Kulldorff M., Feuer E. J., Miller B. A., Freedman L. S. Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol. 1997 Jul 15;146(2):161–170. doi: 10.1093/oxfordjournals.aje.a009247. [DOI] [PubMed] [Google Scholar]
  62. Lan Q., He X., Costa D. J., Tian L., Rothman N., Hu G., Mumford J. L. Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China. Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):605–608. [PubMed] [Google Scholar]
  63. Lander E. S., Linton L. M., Birren B., Nusbaum C., Zody M. C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W. Initial sequencing and analysis of the human genome. Nature. 2001 Feb 15;409(6822):860–921. doi: 10.1038/35057062. [DOI] [PubMed] [Google Scholar]
  64. Landi M. T., Sinha R., Lang N. P., Kadlubar F. F. Human cytochrome P4501A2. IARC Sci Publ. 1999;(148):173–195. [PubMed] [Google Scholar]
  65. Landi S., Hanley N. M., Warren S. H., Pegram R. A., DeMarini D. M. Induction of genetic damage in human lymphocytes and mutations in Salmonella by trihalomethanes: role of red blood cells and GSTT1-1 polymorphism. Mutagenesis. 1999 Sep;14(5):479–482. doi: 10.1093/mutage/14.5.479. [DOI] [PubMed] [Google Scholar]
  66. Lang N. P., Chu D. Z., Hunter C. F., Kendall D. C., Flammang T. J., Kadlubar F. F. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg. 1986 Nov;121(11):1259–1261. doi: 10.1001/archsurg.121.11.1259. [DOI] [PubMed] [Google Scholar]
  67. Langholz B., Rothman N., Wacholder S., Thomas D. C. Cohort studies for characterizing measured genes. J Natl Cancer Inst Monogr. 1999;(26):39–42. doi: 10.1093/oxfordjournals.jncimonographs.a024224. [DOI] [PubMed] [Google Scholar]
  68. Langouët S., Coles B., Morel F., Becquemont L., Beaune P., Guengerich F. P., Ketterer B., Guillouzo A. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res. 1995 Dec 1;55(23):5574–5579. [PubMed] [Google Scholar]
  69. London W. T., Evans A. A., Buetow K., Litwin S., McGlynn K., Zhou T., Clapper M., Ross E., Wild C., Shen F. M. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal. Princess Takamatsu Symp. 1995;25:51–60. [PubMed] [Google Scholar]
  70. Lower G. M., Jr, Nilsson T., Nelson C. E., Wolf H., Gamsky T. E., Bryan G. T. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect. 1979 Apr;29:71–79. doi: 10.1289/ehp.792971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Lunn R. M., Helzlsouer K. J., Parshad R., Umbach D. M., Harris E. L., Sanford K. K., Bell D. A. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000 Apr;21(4):551–555. doi: 10.1093/carcin/21.4.551. [DOI] [PubMed] [Google Scholar]
  72. Marchand L. L., Wilkinson G. R., Wilkens L. R. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):495–500. [PubMed] [Google Scholar]
  73. Marcus P. M., Hayes R. B., Vineis P., Garcia-Closas M., Caporaso N. E., Autrup H., Branch R. A., Brockmöller J., Ishizaki T., Karakaya A. E. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):461–467. [PubMed] [Google Scholar]
  74. Marcus P. M., Vineis P., Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics. 2000 Mar;10(2):115–122. doi: 10.1097/00008571-200003000-00003. [DOI] [PubMed] [Google Scholar]
  75. Mattano S. S., Land S., King C. M., Weber W. W. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase. Mol Pharmacol. 1989 May;35(5):599–609. [PubMed] [Google Scholar]
  76. McGlynn K. A., Rosvold E. A., Lustbader E. D., Hu Y., Clapper M. L., Zhou T., Wild C. P., Xia X. L., Baffoe-Bonnie A., Ofori-Adjei D. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2384–2387. doi: 10.1073/pnas.92.6.2384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. McWilliams J. E., Sanderson B. J., Harris E. L., Richert-Boe K. E., Henner W. D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):589–594. [PubMed] [Google Scholar]
  78. Mendez M., Sorkin L., Rossetti M. V., Astrin K. H., del C Batlle A. M., Parera V. E., Aizencang G., Desnick R. J. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. Am J Hum Genet. 1998 Nov;63(5):1363–1375. doi: 10.1086/302119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Merlo F., Andreassen A., Weston A., Pan C. F., Haugen A., Valerio F., Reggiardo G., Fontana V., Garte S., Puntoni R. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):147–155. [PubMed] [Google Scholar]
  80. Moran-Jimenez M. J., Ged C., Romana M., Enriquez De Salamanca R., Taïeb A., Topi G., D'Alessandro L., de Verneuil H. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet. 1996 Apr;58(4):712–721. [PMC free article] [PubMed] [Google Scholar]
  81. Moran J. L., Siegel D., Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8150–8155. doi: 10.1073/pnas.96.14.8150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Motykiewicz G., Michalska J., Pendzich J., Małusecka E., Strózyk M., Kalinowska E., Butkiewicz D., Mielzyńska D., Midro A., Santella R. M. A molecular epidemiology study in women from Upper Silesia, Poland. Toxicol Lett. 1998 Aug;96-97:195–202. doi: 10.1016/s0378-4274(98)00072-1. [DOI] [PubMed] [Google Scholar]
  83. Nebert D. W., McKinnon R. A., Puga A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol. 1996 Apr;15(4):273–280. doi: 10.1089/dna.1996.15.273. [DOI] [PubMed] [Google Scholar]
  84. Nebert Daniel W. Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypes. Hum Mutat. 2002 Dec;20(6):463–472. doi: 10.1002/humu.10143. [DOI] [PubMed] [Google Scholar]
  85. Nielsen P. S., de Pater N., Okkels H., Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers--effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis. 1996 May;17(5):1021–1027. doi: 10.1093/carcin/17.5.1021. [DOI] [PubMed] [Google Scholar]
  86. Norppa H., Hirvonen A., Järventaus H., Uusküla M., Tasa G., Ojajärvi A., Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis. 1995 Jun;16(6):1261–1264. doi: 10.1093/carcin/16.6.1261. [DOI] [PubMed] [Google Scholar]
  87. Olden K., Wilson S. Environmental health and genomics: visions and implications. Nat Rev Genet. 2000 Nov;1(2):149–153. doi: 10.1038/35038586. [DOI] [PubMed] [Google Scholar]
  88. Pegram R. A., Andersen M. E., Warren S. H., Ross T. M., Claxton L. D. Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: contrasting results with bromodichloromethane off chloroform. Toxicol Appl Pharmacol. 1997 May;144(1):183–188. doi: 10.1006/taap.1997.8123. [DOI] [PubMed] [Google Scholar]
  89. Pemble S., Schroeder K. R., Spencer S. R., Meyer D. J., Hallier E., Bolt H. M., Ketterer B., Taylor J. B. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994 May 15;300(Pt 1):271–276. doi: 10.1042/bj3000271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Perera F. P. Environment and cancer: who are susceptible? Science. 1997 Nov 7;278(5340):1068–1073. doi: 10.1126/science.278.5340.1068. [DOI] [PubMed] [Google Scholar]
  91. Persson I., Johansson I., Ingelman-Sundberg M. In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem Biophys Res Commun. 1997 Feb 3;231(1):227–230. doi: 10.1006/bbrc.1997.6051. [DOI] [PubMed] [Google Scholar]
  92. Raftogianis R. B., Wood T. C., Otterness D. M., Van Loon J. A., Weinshilboum R. M. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun. 1997 Oct 9;239(1):298–304. doi: 10.1006/bbrc.1997.7466. [DOI] [PubMed] [Google Scholar]
  93. Ratnasinghe D., Yao S. X., Tangrea J. A., Qiao Y. L., Andersen M. R., Barrett M. J., Giffen C. A., Erozan Y., Tockman M. S., Taylor P. R. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):119–123. [PubMed] [Google Scholar]
  94. Rebbeck T. R., Jaffe J. M., Walker A. H., Wein A. J., Malkowicz S. B. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst. 1998 Aug 19;90(16):1225–1229. doi: 10.1093/jnci/90.16.1225. [DOI] [PubMed] [Google Scholar]
  95. Richeldi L., Kreiss K., Mroz M. M., Zhen B., Tartoni P., Saltini C. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med. 1997 Oct;32(4):337–340. doi: 10.1002/(sici)1097-0274(199710)32:4<337::aid-ajim3>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  96. Richeldi L., Sorrentino R., Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 1993 Oct 8;262(5131):242–244. doi: 10.1126/science.8105536. [DOI] [PubMed] [Google Scholar]
  97. Rosipal R., Lamoril J., Puy H., Da Silva V., Gouya L., De Rooij F. W., Te Velde K., Nordmann Y., Martàsek P., Deybach J. C. Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update. Hum Mutat. 1999;13(1):44–53. doi: 10.1002/(SICI)1098-1004(1999)13:1<44::AID-HUMU5>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  98. Ross D., Traver R. D., Siegel D., Kuehl B. L., Misra V., Rauth A. M. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br J Cancer. 1996 Sep;74(6):995–996. doi: 10.1038/bjc.1996.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Ross R. K., Yuan J. M., Yu M. C., Wogan G. N., Qian G. S., Tu J. T., Groopman J. D., Gao Y. T., Henderson B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 1992 Apr 18;339(8799):943–946. doi: 10.1016/0140-6736(92)91528-g. [DOI] [PubMed] [Google Scholar]
  100. Rothman N., Garcia-Closas M., Stewart W. T., Lubin J. The impact of misclassification in case-control studies of gene-environment interactions. IARC Sci Publ. 1999;(148):89–96. [PubMed] [Google Scholar]
  101. Rothman N., Smith M. T., Hayes R. B., Traver R. D., Hoener B., Campleman S., Li G. L., Dosemeci M., Linet M., Zhang L. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997 Jul 15;57(14):2839–2842. [PubMed] [Google Scholar]
  102. Rothman N., Stewart W. F., Schulte P. A. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):301–311. [PubMed] [Google Scholar]
  103. Rothman N., Wacholder S., Caporaso N. E., Garcia-Closas M., Buetow K., Fraumeni J. F., Jr The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta. 2001;1471(2):C1–10. doi: 10.1016/s0304-419x(00)00021-4. [DOI] [PubMed] [Google Scholar]
  104. Rushton G., Lolonis P. Exploratory spatial analysis of birth defect rates in an urban population. 1996 Apr 15-May 15Stat Med. 15(7-9):717–726. doi: 10.1002/(sici)1097-0258(19960415)15:7/9<717::aid-sim243>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  105. Sachse C., Brockmöller J., Bauer S., Roots I. Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol. 1999 Apr;47(4):445–449. doi: 10.1046/j.1365-2125.1999.00898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Saltini C., Amicosante M., Franchi A., Lombardi G., Richeldi L. Immunogenetic basis of environmental lung disease: lessons from the berylliosis model. Eur Respir J. 1998 Dec;12(6):1463–1475. doi: 10.1183/09031936.98.12061463. [DOI] [PubMed] [Google Scholar]
  107. Sams C., Mason H. J., Rawbone R. Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Toxicol Lett. 2000 Aug 16;116(3):217–221. doi: 10.1016/s0378-4274(00)00221-6. [DOI] [PubMed] [Google Scholar]
  108. Schaaf B. M., Seitzer U., Pravica V., Aries S. P., Zabel P. Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med. 2001 Feb;163(2):379–382. doi: 10.1164/ajrccm.163.2.2002062. [DOI] [PubMed] [Google Scholar]
  109. Schaid Daniel J., Rowland Charles M., Tines David E., Jacobson Robert M., Poland Gregory A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2001 Dec 27;70(2):425–434. doi: 10.1086/338688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Schwartz B. S., Lee B. K., Lee G. S., Stewart W. F., Simon D., Kelsey K., Todd A. C. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000 Oct;108(10):949–954. doi: 10.1289/ehp.00108949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Schwartz B. S., Lee B. K., Stewart W., Ahn K. D., Springer K., Kelsey K. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol. 1995 Oct 1;142(7):738–745. doi: 10.1093/oxfordjournals.aje.a117705. [DOI] [PubMed] [Google Scholar]
  112. Schwartz B. S., Lee B. K., Stewart W., Sithisarankul P., Strickland P. T., Ahn K. D., Kelsey K. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med. 1997 Apr;54(4):241–246. doi: 10.1136/oem.54.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Schwartz B. S., Stewart W. F., Kelsey K. T., Simon D., Park S., Links J. M., Todd A. C. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect. 2000 Mar;108(3):199–203. doi: 10.1289/ehp.00108199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Seidegård J., Vorachek W. R., Pero R. W., Pearson W. R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7293–7297. doi: 10.1073/pnas.85.19.7293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Shen M. R., Jones I. M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998 Feb 15;58(4):604–608. [PubMed] [Google Scholar]
  116. Shi M. M. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Clin Chem. 2001 Feb;47(2):164–172. [PubMed] [Google Scholar]
  117. Smart J., Daly A. K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics. 2000 Feb;10(1):11–24. doi: 10.1097/00008571-200002000-00003. [DOI] [PubMed] [Google Scholar]
  118. Spurr N. K., Gough A. C., Stevenson K., Wolf C. R. Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res. 1987 Jul 24;15(14):5901–5901. doi: 10.1093/nar/15.14.5901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Stresser D. M., Kupfer D. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation. Drug Metab Dispos. 1998 Sep;26(9):868–874. [PubMed] [Google Scholar]
  120. Sweeney C., Farrow D. C., Schwartz S. M., Eaton D. L., Checkoway H., Vaughan T. L. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):449–454. [PubMed] [Google Scholar]
  121. Tanabe H., Ohhira M., Ohtsubo T., Watari J., Yokota K., Kohgo Y. Genetic polymorphism of aldehyde dehydrogenase 2 in patients with upper aerodigestive tract cancer. Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):17S–20S. doi: 10.1111/j.1530-0277.1999.tb04527.x. [DOI] [PubMed] [Google Scholar]
  122. Taylor J. A., Umbach D. M., Stephens E., Castranio T., Paulson D., Robertson C., Mohler J. L., Bell D. A. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res. 1998 Aug 15;58(16):3603–3610. [PubMed] [Google Scholar]
  123. Thomas Duncan C., Witte John S. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):505–512. [PubMed] [Google Scholar]
  124. Trinidad A., Hein D. W., Rustan T. D., Ferguson R. J., Miller L. S., Bucher K. D., Kirlin W. G., Ogolla F., Andrews A. F. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase. Cancer Res. 1990 Dec 15;50(24):7942–7949. [PubMed] [Google Scholar]
  125. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett. 2000 Mar 15;112-113:209–217. doi: 10.1016/s0378-4274(99)00271-4. [DOI] [PubMed] [Google Scholar]
  126. Vandale S. E., Bingham E. A curriculum for environmental genetics education. Am J Prev Med. 2000 Oct;19(3):197–201. doi: 10.1016/s0749-3797(00)00200-2. [DOI] [PubMed] [Google Scholar]
  127. Venter J. C., Adams M. D., Myers E. W., Li P. W., Mural R. J., Sutton G. G., Smith H. O., Yandell M., Evans C. A., Holt R. A. The sequence of the human genome. Science. 2001 Feb 16;291(5507):1304–1351. doi: 10.1126/science.1058040. [DOI] [PubMed] [Google Scholar]
  128. Viezzer C., Norppa H., Clonfero E., Gabbani G., Mastrangelo G., Hirvonen A., Celotti L. Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat Res. 1999 Dec 17;431(2):259–269. doi: 10.1016/s0027-5107(99)00169-4. [DOI] [PubMed] [Google Scholar]
  129. Wacholder S., Rothman N., Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 2000 Jul 19;92(14):1151–1158. doi: 10.1093/jnci/92.14.1151. [DOI] [PubMed] [Google Scholar]
  130. Walker A. H., Jaffe J. M., Gunasegaram S., Cummings S. A., Huang C. S., Chern H. D., Olopade O. I., Weber B. L., Rebbeck T. R. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online. Hum Mutat. 1998;12(4):289–289. [PubMed] [Google Scholar]
  131. Walker A. H., Najarian D., White D. L., Jaffe J. F., Kanetsky P. A., Rebbeck T. R. Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect. 1999 Jul;107(7):517–520. doi: 10.1289/ehp.99107517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Ward M. H., Nuckols J. R., Weigel S. J., Maxwell S. K., Cantor K. P., Miller R. S. Identifying populations potentially exposed to agricultural pesticides using remote sensing and a Geographic Information System. Environ Health Perspect. 2000 Jan;108(1):5–12. doi: 10.1289/ehp.001085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Watanabe T., Kaji H., Takashima M., Kasai T., Lewtas J., Hirayama T. Metabolic activation of 2- and 3-nitrodibenzopyranone isomers and related compounds by rat liver S9 and the effect of S9 on the mutational specificity of nitrodibenzopyranones. Mutat Res. 1997 Jan 15;388(1):67–78. doi: 10.1016/s1383-5718(96)00138-6. [DOI] [PubMed] [Google Scholar]
  134. Wetmur J. G. Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden. Environ Health Perspect. 1994 Sep;102 (Suppl 3):215–219. doi: 10.1289/ehp.94102s3215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Whyatt R. M., Perera F. P., Jedrychowski W., Santella R. M., Garte S., Bell D. A. Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):207–212. [PubMed] [Google Scholar]
  136. Wiebel F. A., Dommermuth A., Thier R. The hereditary transmission of the glutathione transferase hGSTT1-1 conjugator phenotype in a large family. Pharmacogenetics. 1999 Apr;9(2):251–256. [PubMed] [Google Scholar]
  137. Wiencke J. K., Pemble S., Ketterer B., Kelsey K. T. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):253–259. [PubMed] [Google Scholar]
  138. Wild C. P., Turner P. C. Exposure biomarkers in chemoprevention studies of liver cancer. IARC Sci Publ. 2001;154:215–222. [PubMed] [Google Scholar]
  139. Williams J. A. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis. 2001 Feb;22(2):209–214. doi: 10.1093/carcin/22.2.209. [DOI] [PubMed] [Google Scholar]
  140. Wu M. T., Huang S. L., Ho C. K., Yeh Y. F., Christiani D. C. Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):823–829. [PubMed] [Google Scholar]
  141. Xu X., Kelsey K. T., Wiencke J. K., Wain J. C., Christiani D. C. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):687–692. [PubMed] [Google Scholar]
  142. Xu X., Wiencke J. K., Niu T., Wang M., Watanabe H., Kelsey K. T., Christiani D. C. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am J Ind Med. 1998 Feb;33(2):157–163. doi: 10.1002/(sici)1097-0274(199802)33:2<157::aid-ajim7>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  143. Yokoyama A., Muramatsu T., Omori T., Matsushita S., Yoshimizu H., Higuchi S., Yokoyama T., Maruyama K., Ishii H. Alcohol and aldehyde dehydrogenase gene polymorphisms influence susceptibility to esophageal cancer in Japanese alcoholics. Alcohol Clin Exp Res. 1999 Nov;23(11):1705–1710. [PubMed] [Google Scholar]
  144. Yokoyama A., Ohmori T., Muramatsu T., Higuchi S., Yokoyama T., Matsushita S., Matsumoto M., Maruyama K., Hayashida M., Ishii H. Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype. Int J Cancer. 1996 Nov 4;68(3):313–316. doi: 10.1002/(SICI)1097-0215(19961104)68:3<313::AID-IJC8>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  145. Zheng W., Xie D., Cerhan J. R., Sellers T. A., Wen W., Folsom A. R. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):89–94. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES